HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

4-fluoro-N-indan-2-yl-benzamide

nitric oxide synthase transcription enhancer that ameliorates portal hypertension
Also Known As:
AVE 9488; AVE-9488; AVE9488
Networked: 7 relevant articles (2 outcomes, 1 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Bauersachs, Johann: 3 articles (04/2009 - 01/2008)
2. Ertl, Georg: 2 articles (04/2009 - 08/2008)
3. Fraccarollo, Daniela: 2 articles (04/2009 - 08/2008)
4. Ruetten, Hartmut: 2 articles (08/2008 - 05/2008)
5. Widder, Julian D: 2 articles (08/2008 - 01/2008)
6. Tillmanns, J: 1 article (11/2009)
7. Podolskaya, A: 1 article (11/2009)
8. Fraccarollo, D: 1 article (11/2009)
9. Held, M: 1 article (11/2009)
10. Widder, J D: 1 article (11/2009)

Related Diseases

1. Myocardial Infarction
2. Portal Hypertension
3. Ventricular Remodeling
4. Heart Failure
5. Neointima

Related Drugs and Biologics

1. Nitric Oxide Synthase (NO Synthase)
2. Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)
3. Brain Natriuretic Peptide (Natrecor)
4. Endothelin-1 (Endothelin 1)
5. Superoxides (Superoxide)
6. Atrial Natriuretic Factor (ANF)
7. Hydroxymethylglutaryl CoA Reductases (HMG CoA Reductase)
8. Apolipoproteins E (ApoE)
9. 2,2- difluorobenzo(1,3)dioxole- 5- carboxylic acid indan-2-ylamide
10. erucylphosphocholine

Related Therapies and Procedures

1. Ligation